• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-20
Device Problems Obstruction of Flow (2423); Infusion or Flow Problem (2964); Material Integrity Problem (2978)
Patient Problems High Blood Pressure/ Hypertension (1908); Pain (1994); Vomiting (2144); Shaking/Tremors (2515); Insufficient Information (4580)
Event Date 11/08/2022
Event Type  Injury  
Event Description
Information was received from a consumer via a manufacturer representative regarding a patient who was receiving dilaudid (hydromorp hone) (30 mg/ml at 3.39 mg/day) via an implantable pump for unknown indications for use.It was reported that since the patient's standard eri (early replacement indicator) pump replacement on (b)(6) 2022, the next day (b)(6) 2022 the patient noticed withdrawal symptoms and was feeling unwell.The patient reported shakes, vomiting, increased blood pressure, and increased pain.It was noted that at time of the pump replacement on (b)(6) 2022, the physician accidentally cut the catheter (which was already deemed patent and functioning properly via aspiration from the cap (catheter access port)) while trying to free the catheter up from tissue around it.The physician then used a proximal splice kit and reconnected the catheter pieces together. a pump check was ordered on (b)(6) 2022 by the physician.During the pump/catheter check, the physician was unable to aspirate the catheter at all.A revision catheter surgery was scheduled for (b)(6) 2022.In the mean time, the physician was going to supplement the patient with oral medication.The issue was not resolved at the time of report.The patient's weight and medical history were asked but unknown.The patient's status at the time of report was listed as "alive - no injury".
 
Manufacturer Narrative
Concomitant medical devices: product id: 8780, serial/lot#: (b)(4), implanted: (b)(6) 2016, product type catheter, product id: 8784, serial/lot#: (b)(4), implanted: (b)(6) 2022, product type catheter.Other relevant device(s) are: product id: 8780, serial/lot #: (b)(4), ubd: 05-feb-2018, udi#: (b)(4); product id: 8784, serial/lot #: (b)(4), ubd: 30-sep-2023, udi#: (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Continuation of d10: product id 8780 lot# serial (b)(6) implanted: on (b)(6) 2016 : product type catheter product id 8784 lot# serial (b)(6) implanted: on (b)(6) 2022 explanted: on (b)(6)2022 product type catheter medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a healthcare provider (hcp) via a company representative (rep) reporting the catheter revision occurred as planned on (b)(6) 2022.After close inspection of all connection sites, it appeared the issue may have been at the sutureless connector piece.It looked as if tissue was inside the sutureless connector clogging it up.A new proximal catheter piece with a new sutureless connector was used.The hcp then accessed the catheter access port (cap) and the catheter was easily aspirated.
 
Manufacturer Narrative
Continuation of d10: product id 8780 lot# serial# (b)(6), implanted: (b)(6) 2016, product type catheter product id 8784, serial# (b)(6), implanted: (b)(6) 2022, explanted: (b)(6) 2022, product type catheter.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from the company representative (rep) reporting that replacing the catheter piece resolved the issue.
 
Manufacturer Narrative
H3: analysis of catheter model 8780 with serial number (b)(6) found no significant anomaly ¿catheter body melted at or after explant ¿ did not affect infusion¿.Analysis of catheter model 8784 with serial number hg5qlla01 found ¿catheter body ¿ slice cut not related to explant damage¿ and ¿biological material in cup of sc (sutureless connector) connector¿.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key15840732
MDR Text Key304101570
Report Number3004209178-2022-15368
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00763000634094
UDI-Public00763000634094
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/28/2024
Device Model Number8637-20
Device Catalogue Number8637-20
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 11/16/2022
Initial Date FDA Received11/21/2022
Supplement Dates Manufacturer Received12/22/2022
12/30/2022
03/03/2023
Supplement Dates FDA Received12/27/2022
01/04/2023
03/06/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
"SEE H10...."
Patient Outcome(s) Required Intervention;
Patient Age46 YR
Patient SexMale
-
-